RIKEN Scales Quantum-Supercomputing in Japan with Quantinuum System Upgrade
Quantinuum’s H2 quantum computer to expand the scope and accuracy of pharmaceutical and materials science research using the Reimei-Fugaku hybrid compute platform
April 16, 2026
Tokyo, Japan, April 14th, 2026 — Quantinuum, a leading quantum computing company, today announced that RIKEN, Japan’s premier national research institute, has procured its System Model H2 quantum computer to scale the capability of “Reimei-Fugaku,” a hybrid quantum-supercomputer platform in Japan.
The Reimei-Fugaku platform represents the frontier of computing technology. Launched in the spring of 2025, it combines Quantinuum’s "Reimei" quantum system with RIKEN’s "Fugaku," one of the world’s fastest supercomputers—more formally known as a high-performance computing (HPC) system.
Now, the hybrid compute platform is getting a substantial upgrade. Earlier this month, Quantinuum delivered its H2 system to RIKEN’s research facility near Tokyo, where assembly is already underway to replace its predecessor, System Model H1, which Reimei has been based on to date. The newer-generation, 56-qubit system is engineered for high-fidelity operations that can reduce time-to-solution, enable larger workloads, and support higher-value applications.
Technology leaders see hybrid compute systems as a practical way to overcome the limits of classical HPC. By combining the significant data-processing power of HPC with a quantum computer’s ability to model complex molecules and materials, researchers could be enabled to solve specialized mathematical problems that are impractical for classical systems to handle alone.
Researchers have already demonstrated this potential using the current Reimei-Fugaku platform. In a workflow with relevance potentially extending to future pharmaceutical applications, they successfully simulated biomolecular reactions at an accuracy that would be infeasible for HPC to achieve in isolation.
With multiple studies in chemistry and materials science already underway on the platform, this H2 upgrade is expected to accelerate research and unlock even more complex scientific discoveries across disciplines.
Dr. Mitsuhisa Sato, Division Director of the Quantum-HPC Hybrid Platform Division, RIKEN Center for Computational Science, said: “Since its installation in February 2025, Reimei H1 has been widely used by JHPC-quantum users and has delivered significant results, thanks to its high fidelity and flexible qubit connectivity. The upgrade to H2 is exactly what we have been eagerly anticipating, and with its 56 qubits, we expect it to play a key role in demonstrating quantum advantage through quantum–HPC hybrid computing.”
Dr. Rajeeb Hazra, President and CEO of Quantinuum, said: “We believe RIKEN’s decision to continue adopting Quantinuum systems to meet its ambitious objectives is a validation of our technology roadmap and a reflection of the success of our valued partnership. With Quantinuum and RIKEN’s combined leadership in quantum and HPC, respectively, we expect to continue pushing the boundaries of computing to address some of the most critical and complex challenges facing science and industry today.”
This development reflects the continued progress of Quantinuum and RIKEN’s collaboration to advance quantum-HPC hybrid infrastructure in Japan. Quantinuum intends to continue working with the country’s research community to accelerate real-world use cases and contribute to the growth of its quantum ecosystem.
About RIKEN
RIKEN, a National Research and Development Agency, is Japan’s leading national comprehensive research institution renowned for high-quality research in a diverse range of scientific disciplines. Founded in 1917, initially as a private research foundation, RIKEN has grown rapidly in size and scope, today encompassing a network of world-class research centers and institutes across Japan.
About Quantinuum
Quantinuum is a leading quantum computing company offering a full-stack platform designed to make quantum computing deployable in real-world environments. The company has commercially deployed multiple generations of quantum systems built on the well-established QCCD architecture, which it has implemented with novel designs and capabilities to achieve the industry’s highest accuracy levels based on average two-qubit gate fidelity.[i] Quantinuum has active engagements with market leaders across pharmaceuticals, material science, financial services, and government and industrial markets.
The company has a global workforce of approximately 700 employees, including top scientists and researchers. Over 70% of its technology team hold PhDs. Quantinuum’s headquarters is in Broomfield, Colorado, with additional facilities across the United States, United Kingdom, Germany, Japan, and Singapore.
Quantinuum, the world’s largest integrated quantum company, pioneers powerful quantum computers and advanced software solutions. Quantinuum’s technology drives breakthroughs in materials discovery, cybersecurity, and next-gen quantum AI. With over 500 employees, including 370+ scientists and engineers, Quantinuum leads the quantum computing revolution across continents.
September 11, 2026
Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
BROOMFIELD, Colo., September 11, 2026 - Quantinuum Inc. (Nasdaq: QNT) (the “Company”), a leading quantum computing company, today announced that members of its management team will participate in the Piper Sandler 5th Annual Growth Frontiers Conference, taking place September 14–16, 2026, in Nashville, Tennessee.
Quantinuum will participate in a fireside chat and host one-on-one meetings with investors during the conference.
About Quantinuum
Quantinuum is a leading quantum computing company offering a full-stack platform designed to make quantum computing deployable in real-world environments. The company has commercially deployed multiple generations of trapped-ion based quantum systems built on the well-established QCCD architecture, which it has implemented with novel designs and capabilities to achieve the industry’s highest accuracy levels based on average two-qubit gate fidelity. Quantinuum has active engagements with market leaders across pharmaceuticals, material science, financial services, and government and industrial markets, as well as academic and research institutions globally.
The company has a global workforce of approximately 800 employees, including top scientists and researchers. Over 70% of its technology team holds PhDs or Master’s degrees. Quantinuum’s headquarters is in Broomfield, Colorado, with additional facilities across the United States, United Kingdom, Germany, Japan, Qatar, and Singapore.
Quantinuum Finalizes $100 Million CHIPS R&D Award with U.S. Department of Commerce to Advance Trapped-Ion Quantum Computer Manufacturing in the US
The federal funding supports critical R&D and U.S. quantum semiconductor manufacturing capabilities needed to scale fault-tolerant trapped-ion quantum computing.
Company partnering with GlobalFoundries to fabricate next-gen ion traps and control electronics, and Monarch Quantum to develop and manufacture reliable lasers and optical components.
Washington, D.C. – September 8, 2026 – Quantinuum (Nasdaq: QNT), a leading quantum computing company, today announced it has finalized an agreement with the U.S. Department of Commerce’s CHIPS Research and Development Office for $100 million in federal funding deployed through the CHIPS and Science Act. The award, which follows a letter of intent announced in May, supports R&D and U.S. quantum semiconductor manufacturing capabilities needed to deploy large-scale, fault-tolerant trapped-ion quantum computers.
Quantinuum, which was the only company with a trapped-ion based architecture to be awarded CHIPS R&D funding, develops the world’s most accurate commercial1 computers with industry-leading error correction fidelity.2 The company leverages established semiconductor manufacturing processes to help ensure reliability, repeatability, and scalability of the company’s current and future quantum computers.
“This award is a validation of Quantinuum’s leadership in trapped-ion quantum computing," said Dr. Rajeeb Hazra, President and CEO of Quantinuum. “Together with our domestic partners, we are building the technology and supply-chain foundation needed to scale fault-tolerant systems and strengthen America's leadership in this strategically important field.”
The award will support R&D that the company expects to help strengthen and diversify its supply chain, adding onshore partners GlobalFoundries and Monarch Quantum. GlobalFoundries will be one of several of Quantinuum’s foundries enlisted to fabricate its next-generation ion traps and other electronics, specifically focused on using 300mm wafer technology; Monarch Quantum plans to develop and manufacture scalable, reliable lasers and optical components required for Quantinuum’s trapped-ion systems.
“As quantum computing moves closer to commercial scale, manufacturing will be critical to unlocking its full potential,” said Tim Breen, CEO of GlobalFoundries. “GlobalFoundries is proud to partner with Quantinuum to help scale their trapped-ion technology. By bringing our expertise in high-volume, differentiated semiconductor manufacturing, we're helping create a path to more scalable, reliable quantum hardware and advancing the next generation of American innovation.”
“The road to large-scale, trapped-ion quantum computers relies on moving away from complex, sprawling optical setups to scalable, reliable integrated photonics engines," said Dr. Timothy Day, CEO of Monarch Quantum. "We are honored to expand our partnership with Quantinuum to advance their hardware roadmap and to help strengthen U.S. leadership in quantum computing manufacturing and supply chain resilience.”
Together, these efforts are intended to reduce system complexity and improve component robustness, reliability, and reproducibility, ultimately supporting the continued scaling of trapped-ion quantum computers, while strengthening domestic capability across critical photonics and semiconductor manufacturing.
About Quantinuum
Quantinuum is a leading quantum computing company offering a full-stack platform designed to make quantum computing deployable in real-world environments. The company has commercially deployed multiple generations of trapped-ion based quantum systems built on the well-established QCCD architecture, which it has implemented with novel designs and capabilities to achieve the industry’s highest accuracy levels based on average two-qubit gate fidelity.3 Quantinuum has active engagements with market leaders across pharmaceuticals, material science, financial services, and government and industrial markets, as well as academic and research institutions globally. The company has a global workforce of over 800 employees, including top scientists and researchers. Quantinuum’s headquarters is in Broomfield, Colorado, with additional facilities across the United States, United Kingdom, Germany, Japan, Qatar, and Singapore. For more information, please visit www.quantinuum.com.
This press release contains certain statements that may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that are not historical facts. The words “anticipate,” “assume,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “future,” “will,” “seek,” “foreseeable,” the negative version of these words, or similar terms and phrases are intended to identify forward-looking statements. Such statements are based on certain assumptions and assessments made by our management in light of their experience and their perception of historical trends, current economic and industry conditions, expected future developments and other factors they believe to be appropriate. The forward-looking statements included in this release are also subject to a number of material risks and uncertainties, including but not limited to economic, competitive, governmental, and technological factors affecting our operations, markets, products, services and prices. New factors emerge from time to time, and it is not possible for Quantinuum to predict all such factors. For additional information on these and other risks that could affect Quantinuum’s forward-looking statements, see Quantinuum’s risk factors discussed in its filings with the U.S. Securities and Exchange Commission, including its Quarterly Report on Form 10-Q for the period ended June 30, 2026, as such risk factors may be updated from time to time. Any forward-looking statement speaks only as of the date on which it is made, and, except as required by law, Quantinuum does not undertake any obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.
1 Based on physical two-qubit gate fidelity as of December 31, 2025, according to the 2025 Ransford et al. study. 2 As of February 25, 2026, according to the 2026 Dasu et al. study. 3 As of December 31, 2025.
Quantinuum to Participate in the Bernstein 23rd Annual Pan-European Strategic Decisions Conference
BROOMFIELD, Colo., September 4, 2026 - Quantinuum Inc. (Nasdaq: QNT) (the “Company”), a leading quantum computing company, today announced that members of its management team will participate in the Bernstein 23rd Annual Pan-European Strategic Decisions Conference, taking place September 9–10, 2026, in London, United Kingdom.
Quantinuum will participate in a fireside chat and host one-on-one meetings with investors during the conference.
About Quantinuum
Quantinuum is a leading quantum computing company offering a full-stack platform designed to make quantum computing deployable in real-world environments. The company has commercially deployed multiple generations of trapped-ion based quantum systems built on the well-established QCCD architecture, which it has implemented with novel designs and capabilities to achieve the industry’s highest accuracy levels based on average two-qubit gate fidelity. Quantinuum has active engagements with market leaders across pharmaceuticals, material science, financial services, and government and industrial markets, as well as academic and research institutions globally.
The company has a global workforce of approximately 800 employees, including top scientists and researchers. Over 70% of its technology team holds PhDs or Master’s degrees. Quantinuum’s headquarters is in Broomfield, Colorado, with additional facilities across the United States, United Kingdom, Germany, Japan, Qatar, and Singapore.